Learn More
Medchemexpress LLC Avotaciclib hydrochloride | 1983983-41-0 | 99.75% | 317.73 | 50 MG

Supplier: Medchemexpress LLC HY137432B50MG
Avotaciclib hydrochloride is an orally active cyclin-dependent kinase 1 (CDK1) inhibitor. It inhibits the proliferation and induces apoptosis of tumor cells, and can be used in the research of cancers such as pancreatic cancer and lung cancer. This potent compound targets CDK1 activity, which may inhibit cancer stem cell division, lead to cell cycle arrest, and induce apoptosis, thereby inhibiting tumor cell proliferation.
- Orally active CDK1 inhibitor
- Inhibits proliferation and induces apoptosis of tumor cells
- Useful in research for cancers such as pancreatic cancer and lung cancer
- Targets and inhibits CDK1 activity
- May inhibit cancer stem cell division
- Leads to cell cycle arrest
- Induces apoptosis
- Potential antitumor activity
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.